Molecular testing of cytology specimens: overview of assay selection with focus on lung, salivary gland, and thyroid testing

Paul A. VanderLaan, Sinchita Roy-Chowdhuri, Christopher C. Griffith, Vivian L. Weiss, Christine N. Booth

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

Ancillary and molecular testing of cytopathology specimens has emerged as a reliable and useful tool to provide diagnostic information and treatment-related biomarker status for the management of cancer patients. The cytology specimens obtained through minimally invasive means have proven suitable testing substrates for a variety of ancillary tests, including immunohistochemistry, fluorescence in situ hybridization, as well as polymerase chain reaction and next generation sequencing molecular techniques. By focusing specifically on the cytology specimen, this review provides an overview of basic testing considerations and assay selection in addition to updates on the ancillary testing of cytologic tumor specimens from the lung, salivary gland, and thyroid.

Original languageEnglish (US)
Pages (from-to)403-414
Number of pages12
JournalJournal of the American Society of Cytopathology
Volume11
Issue number6
DOIs
StatePublished - Nov 1 2022

Keywords

  • Cytology
  • FISH
  • Lung
  • Molecular testing
  • Next generation sequencing
  • Salivary gland
  • Thyroid

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint

Dive into the research topics of 'Molecular testing of cytology specimens: overview of assay selection with focus on lung, salivary gland, and thyroid testing'. Together they form a unique fingerprint.

Cite this